Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in Asthma and COPD
NCT04319705Phase 4Unknown
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Mar 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in asthma, chronic obstructive pulmonary disease (COPD), sponsored by Bispebjerg and Frederiksberg Hospital. Status: unknown.
02
Drugs
azithromycin
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04319705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04319705.